We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Agronomics Limited | LSE:ANIC | London | Ordinary Share | IM00B6QH1J21 | ORD 0.0001P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 8.65 | 8.60 | 8.70 | 8.65 | 8.65 | 8.65 | 600,927 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investors, Nec | 30.88M | 22.37M | 0.0222 | 3.90 | 87.31M |
TIDMANIC
RNS Number : 5145K
Agronomics Limited
06 May 2022
6th May 2022
Agronomics Limited
("Agronomics" or the "Company")
Agronomics Follow-on Investment in CellX
Agronomics (AIM:ANIC), the leading listed company focused on the field of cellular agriculture, is pleased to announce it has invested a further US$ 2 million into Chinese cultivated meat company CellX Limited ("CellX"), subscribing for 857,363 preferred shares (the "Subscription"). CellX is a leading cultivated meat company based in Shanghai. Agronomics will have a 5.14% equity ownership in CellX, on a fully diluted basis. The Subscription will be made using cash from the Company's own resources.
Agronomics first invested in CellX in December 2020, with a US$ 50,000 investment in the form of a SAFE ("Simple Agreement for Future Equity"). This SAFE converted to 230,681 preferred shares as stated in the 28th May 2021 announcement . Subject to audit, in aggregate, Agronomics will now carry the combined position in its accounts at a book value of US$ 2,538,117, including an unrealised gain on cost of US$ 488,117, representing an internal rate of return of 458% and a multiple on invested capital of 10.76 of the initial US$ 50,000 investment. The CellX position in the Agronomics portfolio will represent approximately 1.40% of last reported Net Asset Value.
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
About CellX
CellX is a leading cellular agriculture start-up located in Shanghai, the biotech and innovation hub in China. CellX started with domestic Chinese pig breed and has quickly expanded to beef and poultry. With a team of thirty, CellX is working to bring cultivated meat products to consumers in China and around the world. The company is co-founded by two impact entrepreneurs, Ziliang Yang and Ran Liu, and two top scientists, Dr Ning Xiang and Dr Binlu Huang. The team has made significant progress since their founding in 2020, and they have now moved into the next phase of development - scaling up and reducing cost. CellX is collaborating with top universities and leading companies in China and around the world to advance the research and development of cultivated meat, and the company is accelerating market launch and cultivated meat approval as a key player in the APAC region. More information at www.cellx.cn
About Agronomics
Agronomics is a leading listed alternative proteins company with a focus on cellular agriculture and cultivated meat. The Company has established a portfolio of 21 companies at the Pre-Seed to Series C stage in this rapidly advancing sector. It seeks to secure minority stakes in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals, as well as being fundamental to feeding the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/ .
About Cellular Agriculture
Cellular Agriculture is the production of agriculture products directly from cells, as opposed to raising an animal for slaughter, or growing crops. This encompasses cell culture to produce cultivated meat and materials, and fermentation processes that harness a combination of molecular biology, synthetic biology, tissue engineering and biotechnology to massively simplify production methods in a sustainable manner.
Over the coming decades, the source of the world's food supply traditionally derived from conventional agriculture is going to change dramatically. We have already witnessed the first wave of this shift with the consumer adoption of plant-based alternative proteins but today, we are on the cusp of an even bigger wave of change. This is being facilitated by advances in cellular agriculture. This change is necessary, given scientists claims that if we maintain existing animal protein consumption patterns, then we will not meet the Paris Agreement's goal of limiting warming to 1.5
AT Kearney, a global consultancy firm, projects that cultivated meat's market share will reach 35% by 2040. This combined with the Good Food Institute's estimate that a US $1.8 trillion investment will be required in order to produce just 10% of the world's protein using this technology, means that we are on the cusp of a multi-decade flow of capital to build out manufacturing facilities. Funding in the field of cellular agriculture is accelerating, however still less than US$ 2 billion has been invested worldwide since the industry's inception in 2016.
For further information please contact:
Agronomics Beaumont Cenkos Peterhouse Limited Cornish Securities Capital TB Cardew Limited Plc Limited The Company Nomad Joint Broker Joint Broker Public Relations ---------------- --------------- --------------- ------------------------ Richard Reed Roland Cornish Giles Balleny Lucy Williams Ed Orlebar Denham Eke James Biddle Michael Charles Charlotte Anderson Johnson Goodfellow ---------------- --------------- --------------- ------------------------ +44 (0) 20 7930 0777 +44 (0) 1624 +44 (0) +44 (0) +44 (0) +44 (0) 7738 724 639396 207 628 207 397 207 469 630 info@agronomics.im 3396 8900 0936 agronomics@tbcardew.com ---------------- --------------- --------------- ------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCEALSSESLAEFA
(END) Dow Jones Newswires
May 06, 2022 02:00 ET (06:00 GMT)
1 Year Agronomics Chart |
1 Month Agronomics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions